Vidal, A. C., Henry, N. M., Murphy, S. K., Oneko, O., Nye, M., Bartlett, J. A., … Hoyo, C. (2014). PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. Clinical and Translational Oncology, 16(3), 266–272.

Vidal, A. C., N. M. Henry, S. K. Murphy, O. Oneko, M. Nye, J. A. Bartlett, F. Overcash, et al. “PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.” Clinical and Translational Oncology 16, no. 3 (2014): 266–72.

Vidal AC, Henry NM, Murphy SK, Oneko O, Nye M, Bartlett JA, et al. PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. Clinical and Translational Oncology. 2014;16(3):266–72.

Vidal, A. C., et al. “PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.” Clinical and Translational Oncology, vol. 16, no. 3, 2014, pp. 266–72.

Vidal AC, Henry NM, Murphy SK, Oneko O, Nye M, Bartlett JA, Overcash F, Huang Z, Wang F, Mlay P, Obure J, Smith J, Vasquez B, Swai B, Hernandez B, Hoyo C. PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. Clinical and Translational Oncology. 2014;16(3):266–272.